Behavioral Health

Selling Your
Behavioral Health Practice?

Your priorities set the stage.

Merritt Healthcare Advisors represents behavioral health practices, from ABA therapy clinics and outpatient mental health services to addiction treatment and residential care. We focus on sell-side mandates, helping our clients find the right private equity firm, family office, or strategic platform to support their next phase of growth.

The Decision Point

A Decision Worth Making Deliberately.

Staying independent and doing what has always worked used to be the default. It now takes a more deliberate decision.

Most behavioral health practices start with a clinician, not a business plan. A therapist, a psychiatrist, or a BCBA sees a gap in care, opens a practice to help close it, and years later finds themselves running payroll, negotiating payer contracts, and competing for scarce clinical talent against platforms with far deeper pockets, all while the hands-on clinical work that brought them here in the first place seems like a distant memory.

The decision point rarely arrives as one dramatic moment. It can be a record year that makes the value of the practice hard to ignore, a major regulatory change, a competitor’s practice getting acquired, a well-funded competitor moving into town, or simply growing fatigue. None of these alone typically force the question of whether it’s time to monetize, but together they’re what moves a successful owner from building the business to seriously thinking about selling it.

Acquisition Context

Platform or Tuck-In.

Behavioral health has been one of the more active areas of healthcare M&A in recent years, and buyer interest remains strong even as the pace of deal flow has normalized.

As owners consider whether or not to sell at all, an important consideration to help them decide is to understand which side of the investment coin they want to land on: build long enough and grow large enough to become a platform investment, or sell sooner and tuck into an existing company.

Platform Investment

Not every platform investment looks like a headline-making acquisition. In practice, acquiring platform status is much more attainable than the headlines might imply, and platforms often start much smaller: a well-run multi-site group, for instance, that a private equity firm backs as its first acquisition into a vertical. Merritt’s own Behavioral Health lead has been on this side of the table. More in “The Operator’s Perspective” below.

Tuck-In Acquisitions

This is where many behavioral health transactions happen: as a tuck-in to an already existing platform. That’s the same pattern behind how many of the sector’s largest platforms got large in the first place: not through one transaction, but by layering years of tuck-ins onto an original platform, each one a smaller, single- or multi-site practice choosing to join something already built.

Underneath both kinds of deal activity is a genuine access gap that isn’t closing on its own. Demand for behavioral health care continues to outpace the supply of clinicians, large parts of the country face shortages of mental health professionals, and wait times for care remain long in many regions. The sector also remains fragmented, with many small and mid-sized operators, which is the kind of fragmentation private equity looks to consolidate. That gap, combined with clinical demand that keeps outpacing capacity, is what continues pulling strategic and financial buyers into the space.

Tim Plachta

Tim Plachta

Managing Director

Operator Spotlight

Multi-Clinic. Multi-State.
One operator’s perspective.

Merritt’s Behavioral Health practice is led by Tim Plachta, a former behavioral health owner and operator who sold his own practice to a private equity firm before helping to advise others on their transactions. That operating experience directly shapes how our team approaches every behavioral health engagement we take on.

What Drives Value

Value Drivers in Behavioral Health.

Buyers underwrite a behavioral health business on a specific set of factors: clinical staffing and retention, payer mix and reimbursement stability, licensure and regulatory complexity, and how scalable and standardized the clinical model actually is. Owners who understand these levers before going to market are the ones who capture the value that’s actually there.

01

Clinical Staffing and Retention

Personnel is the central operating challenge in most behavioral health businesses, and it shows up directly in valuation. Turnover among clinicians and technicians runs high across the sector, particularly in ABA therapy, and recruiting and training a replacement is costly relative to salary. The strain runs deeper than any one sub-vertical: workforce projections point to continuing shortages of mental health counselors and psychiatrists, and burnout is widespread among behavioral health professionals. Buyers underwrite retention and pipeline strength as carefully as they underwrite revenue, because a staffing gap in this sector doesn’t just compress margin, it can cap how many patients a location can safely serve.

02

Payer Mix and Reimbursement Stability

Payer mix varies enormously by sub-vertical. Cash-pay and commercial-heavy outpatient mental health looks very different from Medicaid-dependent autism services or addiction treatment, and buyers price that difference directly. A practice with diversified, in-network payer relationships and a track record of stable reimbursement reads as materially less risky than one concentrated in a single payer or a single state’s Medicaid program.

03

Licensure and Regulatory Complexity

Behavioral health is licensed and regulated state by state, often facility by facility, and that complexity compounds with multi-state growth. Interstate compacts ease part of the burden for clinicians, but multi-state operators still face real complexity. Addiction treatment carries some of the heaviest accreditation and compliance requirements in healthcare services. Owners who can show a clean, well-documented compliance history remove a major source of buyer hesitation before diligence even starts.

04

Scalability and Clinical Standardization

Multi-site platforms that can point to standardized clinical protocols, consistent outcomes measurement, and a repeatable model for opening or integrating new locations command a premium over single-site or loosely coordinated operations, because that repeatability is exactly what a buyer is underwriting when it plans to keep growing the platform after close.

Buyers price behavioral health businesses the same way they price any healthcare services business: as a multiple of earnings. But that multiple is really shorthand for a forward-looking calculation: buyers project earnings forward and discount them at their own cost of capital, so payer mix, staffing stability, and compliance history matter as much as the trailing financial number. That’s exactly why the value-driver work covered above happens before a business goes to market, not after.

By Sub-Vertical

It Isn’t One Market.

Behavioral health isn’t one market, it’s several adjacent ones, and the special situations differ by sub-vertical. Owners should expect the diligence conversation to look different depending on which of these categories their business actually falls into.

01

Addiction Treatment

Carries one of the heaviest state licensing and accreditation burdens in the sector. Diligence focuses heavily on compliance history and clinical outcomes documentation.

02

Autism & ABA Services

A highly staffing-intensive model. The growth story is directly tied to how reliably a platform can hire and retain clinicians.

03

Outpatient Mental Health

Reshaped by telehealth. Payer-mix questions increasingly hinge on how a practice balances virtual and in-person care.

04

IOP & PHP

Intensive outpatient and partial hospitalization programs are drawing growing buyer interest, as buyers increasingly favor outpatient models that are both clinically effective and cost-effective.

Your Options

More Than Sell-or-Don’t.

Majority Sale

This is a common path in the current market. A private equity firm or an existing platform acquires a majority or full stake. Sometimes the practice becomes the platform, the foundation a private equity firm builds around and adds to. Often it tucks into a platform that already exists. Either way, the practice is integrated into a larger network, often trading its own back office, credentialing, and payer contracting for the buyer’s scale.

Minority Recapitalization

An owner sells a minority, non-controlling stake to a growth partner, retains meaningful ownership and day-to-day clinical control, and uses the partner’s capital and infrastructure to fund growth that would otherwise be difficult to self-finance. This fits owners who aren’t ready to give up control but do want a partner’s balance sheet behind their next phase of growth.

Staying Independent and Growing Organically

Not every owner needs to sell their company right now. Some are better served by staying independent, addressing the staffing, payer-mix, or compliance gaps identified above, and building a stronger position before ever going to market, whether that market conversation happens next year or five years from now.

The Advisory Process

How the Process Works.

01

Confidential Marketing

The practice is introduced to the market without announcing a sale to staff, clients, or referral sources before the owner chooses to.

02

The CIM

The memorandum buyers use to evaluate the business, covering clinical capacity, staffing, payer relationships, and financial results.

03

Buyer Outreach & Screening

Buyers with a real appetite for the sub-sector are invited to compete, whether established platforms or private equity firms entering the space.

04

IOIs & LOI

Buyers submit indications of interest first. The owner then chooses who moves forward to a letter of intent.

05

Diligence & Closing

Clinical decision-making control, staff continuity, licensure transfer, and compliance oversight negotiated alongside price, not as an afterthought.

Timeline: expectations vary more in behavioral health than in some other sectors, largely because state licensing transfers and multi-state compliance review can add real time to a deal that would otherwise move faster. Starting the conversation early, before a forced timeline, gives an owner room to work through that process rather than be rushed by it.

Operator Perspective

From Sell-Side to Buy-Side.

Tim Plachta, Managing Director of Behavioral Health at Merritt Healthcare Advisors, built his expertise from the inside rather than as an outside advisor. Before joining Merritt, he was a principal and co-owner of ABA Connect, growing the practice across the Austin and Houston markets before its 2022 sale, then stayed on through the transition as the resulting platform’s Chief Operating Officer, where he helped execute its first significant acquisition and launch supporting de novo clinics.

That experience, having personally sat on both sides of the negotiating table, gives him a first-hand read on what it takes to get a deal done.

Platform Sale · 2022

ABA Connect

Six-clinic ABA therapy provider across Austin and Houston, acquired by MBF Healthcare Partners II.

Tim’s role: Principal & Co-Owner
Tuck-In Acquisition · 2023

Bright Behavior

Colorado Springs ABA therapy provider, acquired and integrated as ABA Connect’s first acquisition, expanding services into multiple states.

Tim’s role: Chief Operating Officer

These are Tim’s personal, pre-Merritt transactions as an owner and operator, not engagements advised by Merritt Healthcare Advisors.

Frequently Asked Questions

Answers to Start the Discussion.

How is a behavioral health practice actually valued?

Largely on the same underwriting logic as other healthcare services businesses: buyers project earnings forward and discount them at their own cost of capital, so payer mix, staffing stability, and compliance history matter as much as the trailing financial number. That’s exactly why the value-driver work covered above happens before a business goes to market, not after.

How much clinical control do I keep after a partnership?

It depends on the structure you choose. A minority recapitalization is built specifically to preserve day-to-day clinical control while still bringing in growth capital; a full sale into a platform generally means more integration and less independent control. Knowing which trade-off you’re making, and negotiating governance protections into it, is part of what an advisor’s job is.

How long does a behavioral health sale or partnership process take?

It varies more than in some other sectors, largely because of state licensing transfers and multi-state compliance review, which can add real time depending on how many states a business operates in. Starting the conversation early, before you’re under time pressure, gives you room to work through that timeline rather than be forced by it.

Should I run the sale myself or hire an advisor?

Some owners try. But a first-time seller is negotiating against buyers who have done this before and know where the leverage sits, and a sale is rarely just about price. An advisor brings the experience, and the competition, to even that out.

How is working with an investment bank different from going directly to a buyer?

A direct approach puts the owner one-on-one with a buyer that runs this process for a living, with no competing bid to create leverage. An advisor-led process brings several credible buyers to the table and negotiates diligence and terms, not just price, around what the owner wants.

Start a Conversation

Thinking About Selling Your Behavioral Health Practice or Bringing In a Partner?

If you’re weighing whether this is the right time, for a full sale, a partnership, or simply understanding what your practice is actually worth in today’s market, that’s a conversation, not a commitment. Reach out for a confidential discussion to see what your options actually look like.

Schedule Your Appointment Today

Gain insights from the healthcare industry’s leading M&A experts

Merritt Healthcare Advisors (“MHA”) is focused exclusively on representing owners of middle-market healthcare businesses considering strategic options, whether selling an interest in their organization, creating a new partnership or growing through acquisition.